IO Biotech, Inc.
IO Biotech, Inc.（IOBT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · IOBT · 截至 2026年6月9日
活动摘要
买入笔数
5
P-Purchase only
卖出笔数
3
近12个月
买卖比
1.67
Buy/Sell (by trades)
整体情绪
IO Biotech, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
IOBT 季度内部人买卖趋势
IOBT 内幕交易卖出 · IOBT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
IOBT 高管卖出股份 · IOBT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 30, 2025 | Hunter Heidi Director | Purchase | 15,000 | $21K | Form 4 |
| Dec 23, 2024 | Ahmad Qasim Iftikhar Chief Medical Officer | Purchase | 31,350 | $27K | Form 4 |
| Dec 23, 2024 | Zocca Mai-Britt CEO · Director | Purchase | 12,500 | $10K | Form 4 |
| Dec 23, 2024 | Sullivan Amy CFO | Purchase | 10,250 | $8K | Form 4 |
| Dec 23, 2024 | Smith Devin Whittemore General Counsel | Purchase | 12,000 | $10K | Form 4 |
| Nov 22, 2023 | Burkavage Brian CAO | Purchase | 5,000 | $5K | Form 4 |
| Nov 21, 2023 | Burkavage Brian CAO | Purchase | 5,000 | $5K | Form 4 |
| Aug 9, 2023 | Elling Christian E Director | Award | 7,901,234 | $15.01M⚡ | Form 4 |
| Aug 9, 2023 | Lundbeckfond Invest A/S Director | Award | 7,901,234 | $15.01M⚡ | Form 4 |
| Aug 9, 2023 | Novo Holdings A/S 10 percent owner | Purchase | 2,469,135 | $5.00M⚡ | Form 4 |
| Aug 9, 2023 | Vivo Capital IX, LLC 10 percent owner | Purchase | 3,157,894 | $6.00M⚡ | Form 4 |
| Aug 9, 2023 | Zocca Mai-Britt CEO · Director | Award | 37,037 | $70K | Form 4 |
| Aug 9, 2023 | Sullivan Amy CFO | Award | 49,382 | $94K | Form 4 |
| Aug 9, 2023 | Smith Devin Whittemore General Counsel | Award | 4,938 | $9K | Form 4 |
| Mar 17, 2023 | Sullivan Amy CFO | Purchase | 25,000 | $58K | Form 4 |
| Nov 9, 2021 | HBM Healthcare Investments (Cayman) Ltd. 10 percent owner | Purchase | 325,000 | $4.55M⚡ | Form 4 |
| Nov 9, 2021 | HBM Healthcare Investments (Cayman) Ltd. 10 percent owner | Other | 2,365,545 | — | Form 4 |
| Nov 9, 2021 | Malier Vanessa Director | Purchase | 162,500 | $2.27M⚡ | Form 4 |
| Nov 9, 2021 | Malier Vanessa Director | Other | 796,059 | — | Form 4 |
| Nov 9, 2021 | Malier Vanessa Director | Purchase | 162,500 | $2.27M⚡ | Form 4 |
| Nov 9, 2021 | Malier Vanessa Director | Other | 267,977 | — | Form 4 |
| Nov 9, 2021 | Vivo Capital IX, LLC 10 percent owner | Purchase | 650,000 | $9.10M⚡ | Form 4 |
| Nov 9, 2021 | Vivo Capital IX, LLC 10 percent owner | Other | 2,365,545 | — | Form 4 |
| Nov 9, 2021 | Andersson Claus A. Director | Purchase | 75,000 | $1.05M⚡ | Form 4 |
| Nov 9, 2021 | Andersson Claus A. Director | Other | 354,830 | — | Form 4 |
Ahmad Qasim Iftikhar
Chief Medical Officer
日期
Dec 23
股数
31,350
均价
$0.85
总金额
$27K
Vivo Capital IX, LLC
10 percent owner
日期
Aug 9
股数
3,157,894
均价
$1.90
总金额
$6.00M ⚡
HBM Healthcare Investments (Cayman) Ltd.
10 percent owner
日期
Nov 9
股数
325,000
均价
$14.00
总金额
$4.55M ⚡
HBM Healthcare Investments (Cayman) Ltd.
10 percent owner
日期
Nov 9
股数
2,365,545
均价
—
总金额
—
Vivo Capital IX, LLC
10 percent owner
日期
Nov 9
股数
650,000
均价
$14.00
总金额
$9.10M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 IOBT 内幕交易
IOBT 内幕交易
IO Biotech, Inc.（IOBT）内幕交易数据来源于公司内部人（包括IOBT）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。IOBT内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看IO Biotech, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
IOBT 内幕交易 · 5个问题IO Biotech, Inc.（IOBT）的内部人包括高管和董事，如IOBT等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026